正在加载...

Clinical Pharmacology

Clinical Pharmacology and Pharmacometrics

Differentia Biotech provides clinical pharmacology and pharmacometrics services, including the implementation and interpretation of preclinical and clinical pharmacokinetic study data, pharmacometrics, modelling and simulation, guidance on protocol creation, and implementation of research studies and clinical trials. We leverage relevant pharmacological mechanisms to make informed decisions.

Overview

Facilitate Decision-making in the Success of Clinical Research

Utilizing extensive knowledge of drug mechanisms, PK, PD, and MIDD methodologies, we enhance clinical trials with simulations, and can propose dosing regimen optimization in subgroups like children.

We guide market strategies from lead selection to late-stage development, develop effective strategies for meeting regulatory obligations, and optimize study approaches.

Our expertise spans paediatrics, maternal-foetal medicine, oncology, immunological diseases, biologics, and rare diseases.

Service Modules

Clinical Pharmacology, Pharmacometrics and Paediatric Expertise

Clinical Pharmacology
01

Clinical Pharmacology

Support for Phases I, II, and III clinical trials for First-in-Human Dose (FHD), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), and Food Effect.

Design dose selection strategy
ADME studies
PK analysis, interpretation and reporting
Provide initial concepts through New Drug Application (NDA)
Assistance with regulatory compliance
Assess market/clinical needs
Pharmacometrics
02

Pharmacometrics

Enhance drug development success with quantification of exposure-response to optimize clinical trials in time and resources, by preventing adverse events and providing the right dose to the right patient.

Non compartmental analysis (NCA)
Pharmacokinetic (PK) models
Pharmacodynamic (PD) models
PK/PD models
Optimal design
Longitudinal disease modeling
Paediatric expertise
03

Paediatric expertise

We are experienced in providing full service consultative service crossing the research continuum in the following main areas.

Aid in paediatric drug development (PSP or PIP)
Focus on special populations
Maternal and Child Health
Human growth and development
Newborn and Neonatal Individuals
Pediatrics
Chronic medical conditions arising in childhood

Get Started

Book a consultation

Connect with us to explore tailored strategies for navigating complex drug development challenges and accelerating the delivery of safe, effective therapies.